Viewing Study NCT00117351

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-01-16 @ 5:22 AM
Study NCT ID: NCT00117351
Status: TERMINATED
Last Update Posted: 2011-02-17
First Post: 2005-06-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
None Adenocarcinoma, Bronchiolo-Alveolar View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adenocarcinoma View
None Bronchiolo-Alveolar View
None Carcinoma, Bronchioloalveolar View
None Carcinoma, Non-Small-Cell Lung View
None Carcinoma, Bronchiolo-Alveolar View